Year: 2022

MIAMI, Nov. 28, 2022 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI), (“Intermex” or the “Company”) a leading money remittance services company, today announced the Company will present at the UBS Global TMT Conference in New York City on Tuesday, December 6, 2022. The presentation will begin at 2:10 p.m. ET and will include comments from Andras Bende, chief financial officer. Investors and interested parties will be able to listen to the investor presentation via webcast at https://investors.intermexonline.com/news-events/events. The archived webcast will be available shortly after the conclusion of the presentation. About International Money Express, Inc.Founded in 1994, Intermex applies proprietary technology enabling consumers to send money from the United States and Canada to 18 countries in Latin America...

TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 54,498,889 common shares (“Common Shares”) at a price of CAD$0.027 per Common Share for aggregate gross proceeds of CAD$1,471,470 (or US$1,100,000) (the “Offering”). The net proceeds from the sale of the Common Shares will be used to: (i) add manufacturing capacities to extend the production of new cannabinoids isolates and high concentrated THC distillates; (ii) upgrade of the physical infrastructure of the extraction laboratory to comply with Q7A Good Manufacturing Practice guidelines for Active Pharmaceutical ingredients;...

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Virtual Conference on November 30, 2022 at 10:30 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled...

CHANDLER, Ariz., Nov. 28, 2022 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the Credit Suisse 26th Annual Technology Conference on Wednesday, September 14 at 9:15 a.m. (Pacific Time). Presenting for the Company will be Mr. Ganesh Moorthy, Executive Chair. A live webcast of the presentation will be made available by Credit Suisse, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC’s website (www.sec.gov) or from...

SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading energy management platform company accelerating the global transition to a sustainable electrification economy, is scheduled to participate at the following conferences in December 2022: 22nd Annual Advanced Automotive Battery Conference (AABC)Date: Monday, December 5th to Thursday, December 8th, 2022Location: Hotel Del Coronado, 1500 Orange Ave, Coronado, CA, Booth #800Event Detail: The Advanced Automotive Battery Conference (AABC) hosts industry experts that analyze what issues on the technical and business fronts impede the development of vehicle electrification. Attendees will have the opportunity to network with industry leaders that will provide insight into the business outlook and trends on...

FRISCO, TX, Nov. 28, 2022 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (“Comstock” or the “Company”) (NYSE: CRK) announced today that Trey Newell will be joining the Company as Vice President of Corporate Development to support a new initiative to develop new markets for the Company’s natural gas production in the Haynesville shale in East Texas and North Louisiana. Lori Kanaman also recently joined the Company to head up the Company’s natural gas marketing group as Vice President of Marketing. Trey Newell brings two decades of commercial, marketing and operations experience in the midstream energy industry. Prior to joining Comstock, Mr. Newell was responsible for producer relationships, business development, project management, scheduling, and marketing as Commercial and Marketing Vice President...

ST. LOUIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported selected operating results for October 31, 2022 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “The benefits of our client cash initiatives are highlighted by the increase in client deposits in October, which have continued into November. We have been able to successfully retain our existing deposit base and also bring in new cash balances. Client assets and fee-based assets increased 5% as a function of both financial advisor recruiting and appreciation in equity markets. The environment remains challenging for our Institutional...

PONTE VEDRA, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ Procedure, today announced that its SpeedPlate™ Rapid Compression Implant System (“SpeedPlate™”) has received 510(k) clearance from the FDA to be used for fracture fixation, osteotomy fixation, and joint arthrodesis of the foot and ankle. The SpeedPlate™ System was designed for rapid delivery of titanium compression implants, serving as enabling fixation technology with Treace’s new Micro-Lapiplasty® instrumentation which allows the patented Lapiplasty® procedure to be performed through small, 2cm incisions....

WALTHAM, Mass. and BOULDER, Colo., Nov. 28, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Rachael Easton, MD, Ph.D., Vice President, Head of Clinical Development. “We are pleased to welcome Dr. Easton to Cogent as we continue to develop bezuclastinib in Systemic Mastocytosis and GIST,” said Andrew Robbins, the company’s President and Chief Executive Officer. “Dr. Easton is an accomplished physician-scientist who brings a wealth of experience in both early and late-stage clinical development across multiple therapeutic areas. Her background and knowledge will allow us to thoughtfully advance our programs as we work towards bringing important therapies to patients with genetically...